-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$32.00233.68% Upside
REGENXBIO Inc. Frequently Asked Questions
-
What analysts cover REGENXBIO Inc.?
REGENXBIO Inc. has been rated by research analysts at Morgan Stanley, Raymond James, H.C. Wainwright, Stifel Nicolaus, Goldman Sachs, RBC Capital in the past 90 days.